Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager

Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager

US Patent 12049513 · Granted Jul 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing regime and formulations for type B adenoviruses2025
Multispecific anti-TCR delta variable 1 antibodies2025
Adenovirus armed with bispecific T cell engager2025
Adenovirus armed with bispecific T cell engager2025
Adenovirus armed with bispecific T cell engager2025
Adenovirus armed with bispecific T cell engager2025
Adenovirus armed with bispecific T cell engager2025
Group B adenovirus encoding an anti-TCR-complex antibody or fragment2024
Oncolytic adenoviruses armed with heterologous genes2024
Oncolytic adenoviruses armed with heterologous genes2024
Adenovirus armed with bispecific T cell activator2023
Adenovirus armed with bispecific T cell activator2023